Not to correct you Doc, but the startling results are DCVax-L and poly iclc only, so far. We do not yet have results from the combination therapy with Keytruda. I would be anxious to see how much even better those results will very likely be than the incredible results just adding poly iclc as an adjuvant.
I agree - for rGBM. I wouldn't be surprised seeing this same combo used in a basket trial for all indications beyond the rGBM trial where we have already seen the outstanding data.